27 June 2017 - The Pharmacy Guild of Australia has been criticised over attempts to boycott an independent review of the industry after it advised its 5000-plus members against participating in the process.

The industry has also been slammed over its reluctance to provide information that would ensure “accountability and transparency” for the billions of dollars in public funds it receives for dispensing Pharmaceutical Benefits Scheme drugs across the country.

The expert panel overseeing the Turnbull government’s Review of Pharmacy Remuneration and Regulation has called for an end to the guild’s 27-year exclusive hold on the multi-billion dollar community pharmacy agreement, suggesting that other stakeholders, particularly the Consumers Health Forum of Australia and the Pharmaceutical Society of Australia, should be included in future negotiations.

Read The Australian article